| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 364,527 | 386,193 | 334,661 | 344,744 | | Cost of Revenue | 262,176 | 287,094 | 235,539 | 244,286 | | | Gross Profit | 102,351 | 99,099 | 99,122 | 100,458 | | | Operating Expenses | | Research Development | 19,980 | 20,676 | 18,796 | 19,084 | | Selling General and Administrative | 33,947 | 33,182 | 29,093 | 32,460 | | Non Recurring |
-
|
-
| 15,159 |
-
| | Others | 7,951 | 8,286 | 5,055 | 4,828 | | | | Total Operating Expenses |
-
|
-
| 68,103 |
-
| | | | Operating Income or Loss | 40,473 | 36,955 | 31,019 | 44,086 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,819 | 624 | 495 | 570 | | Earnings Before Interest And Taxes | 42,292 | 37,579 | 31,514 | 44,656 | | Interest Expense | 9,499 | 10,886 | 6,707 | 6,537 | | Income Before Tax | 32,793 | 26,693 | 24,807 | 38,119 | | Income Tax Expense | 8,976 | 1,696 | 6,333 | 11,055 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 23,817 | 24,997 | 18,474 | 27,064 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 23,817 | 24,997 | 18,474 | 27,064 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $23,817 | $24,997 | $18,474 | $27,064 |
|
0.11% Nasdaq 
Income Statement
